Optoseeker Biotechnology (Shenzhen) Co., Ltd. was founded in 2023 by a team of professors from the Beijing Institute of Technology, Southern University of Science and Technology, and Jinan University, along with several Ph.D. scholars returning from overseas. Guided by the mission of "empowering life through technology," the company is dedicated to accelerating the translation of scientific breakthroughs in biomedicine, cell therapy, and gene therapy, pioneering a new era of health innovation.
Focusing on foundational technologies in the life sciences, Optoseeker Biotechnology develops advanced instrument platforms to solve critical bottlenecks in the field. Our product portfolio includes biochips, digital microfluidics, and live-cell screening platforms, primarily serving the biopharmaceutical (including AI-driven drug discovery), precision medicine, and synthetic biology sectors.